Table 1.
Characteristics of patients with COVID-19, November 15, 2021 to April 17, 2022.
| Characteristic | N = 1138 (%) |
|---|---|
| Mean age, years (SD) | 66.6 (17.5) |
| Gender | |
| Male | 626 (55.0) |
| Female | 512 (45.0) |
| At least one comorbidity | 826 (72.6) |
| Number of comorbidities* | |
| One | 355 (31.2) |
| Two | 318 (27.9) |
| Three or more | 153 (13.4) |
| Influenza vaccination | 629 (55.3) |
| COVID-19 vaccination | |
| Full vaccination | 386 (33.9) |
| Partial vaccination | 172 (15.1) |
| No vaccination | 580 (51.0) |
| Mean duration from last vaccine dose to diagnosis, days (SD) | 128.9 (81.1) |
| Mean duration from diagnosis to admission, days (SD) | 2.4 (4.6) |
| Mean duration of hospitalization, days (SD) | 10.1 (9.4) |
| Admission to ICU | 75 (6.6) |
| Mean duration in ICU, days (SD) | 18.1 (14.9) |
| Invasive mechanical ventilation | 64 (5.6) |
| Mean duration of mechanical ventilation, days (SD) | 15.5 (15.5) |
| Death | 172 (15.1) |
| Any adverse outcome | 205 (18.0) |
| Healthcare-associated infection** | 92 (8.1) |
COVID-19: coronavirus disease 2019; SD: standard deviation; ICU: intensive care unit.
*
chronic cardiovascular disease (450), diabetes mellitus (234), immunοsupression (171), malignancy (164), obesity (151), chronic neuromuscular disorder (135), chronic pulmonary disease (121), chronic renal disease (77).
**
blood stream infection (32), urinary tract infection (23), lower respiratory tract infection (20), gastrointestinal infection (8), other (9).